GENOLUTION INC. · 주식등의대량보유상황보고서(일반)
Report on large shareholdings (general)
6.1
(주)제놀루션
0000
Report on Large Holdings of Shares, etc.
| (General form: reports under Article 147 of the Financial Investment Services and Capital Markets Act with the purpose of influencing management control) |
| To: Financial Services Commission | Reporting obligation date: | 2026-11-03 |
| To: Korea Exchange | Report reference date: | 2026-11-10 |
| Reporting person: | 김기옥 |
| Summary |
| Issuer name | (주)제놀루션 | Relationship to Issuer | Largest Shareholder |
| Report Type | Change |
| Number of Shares Held and Holding Ratio | | Number of Shares Held | Holding Ratio |
| Previous Report | 5,497,927 | 28.65 |
| Current Report | 5,527,927 | 28.81 |
| Shares under key agreements: number and ratio | | Number of shares, etc. | Ratio |
| Previous Report | 0 | - |
| Current Report | 0 | - |
| Number of voting rights and holding ratio | | Number of Voting Rights | Holding Ratio |
| Previous Report | - | - |
| Current Report | - | - |
| Voting rights under key agreements: number and ratio | | Number of Voting Rights | Ratio |
| Previous Report | - | - |
| Current Report | - | - |
| Reason for Report | On-market purchase |
| ※ The reporting person confirms that holdings of shares, etc. by the reporting person and specially related parties as of the reference date are accurately stated per applicable laws and filing instructions, with no material misstatement or omission. |
Part 1 Report Overview
1. Issuer information
| Company Name | (주)제놀루션 | Company code | 225220 |
| Entity type | KOSDAQ-Listed Company | Total Issued Voting Shares (shares) | 19,190,021 |
2. Major shareholder information
a. Reporting person
(1) Reporting person overview
| Report Type | Change | Joint signatories |
| Reporting person type | Individual (Domestic) | Nationality | Republic of Korea |
| Basis for Reporter Classification (only if reported as a statutory partnership or other entity) | - |
| Name (Entity Name) | Korean | 김기옥 | Chinese characters (English) | Kim Gi Ok |
| Address (Head Office) [Town/District Level Only] | 서울특별시 강동구 둔촌동 | Date of Birth or Business Registration No., etc. | 551002 |
| Occupation (business) | CEO | Relationship to Issuer | Largest Shareholder |
| Business contact and person in charge | Affiliated company | (주)제놀루션 | Department | IR Team |
| Position | General Manager | Phone Number | 070-41*** |
| Name | 이대섭 | Fax number | 02-643** |
| Email address | **@genolution1.com |
(2) Reporting Person Details (for Corporations, Other Organizations, Statutory Associations, or Civil-Law Partnerships)
| Legal form | - |
| Total Assets (or Total Assets Under Management) | - | Total Liabilities | - |
| Total Equity | - | Paid-in Capital | - |
| Representative (representative or managing partner) | - |
| Decision-Making Body (Decision Maker) | - |
| Largest Shareholder (Largest Investor) | - | Largest Shareholder Ownership (%) (Largest Investor Contribution Ratio) | - |
b. Specially related parties
(1) Specially related party overview
| No. | Name | Category | Specific Relationship to Reporter | Date of Birth or Business Registration No., etc. | Nationality | Address (Location) | Occupation (Business) | Relationship to Issuer |
| 1 | 김민이 | Individual (Domestic) | Relatives | 861116 | Republic of Korea | 서울 강서구 양천로 | 제놀루션 대표이사 | Executive officers (registered) |
| 2 | 김민호 | Individual (Domestic) | Relatives | 850701 | Republic of Korea | 서울시 강남구 삼성로 | Executive | Shareholder |
| 3 | KimSangHoon | 개인(외국) | Relatives | 600912 | USA | 경기도 성남시 이매동 | 제놀루션 임원 | Executives (unregistered) |
| 4 | (주)호일바이오메드 | Domestic corporation | Affiliate | 209-81-13983 | Republic of Korea | 서울 송파구 송파대로 | 의료기기 도매업 | Affiliates, etc. |
| 5 | EK Health Services Inc | Foreign Corporation | Affiliate | 77-0497964 | USA | STE 101 SAN JOSE.CA95129 USA | - | Affiliates, etc. |
| 6 | 최영백 | Individual (Domestic) | Relatives | 810521 | Republic of Korea | 서울 강서구 양천로 | - | Shareholder |
| 7 | 김소현 | Individual (Domestic) | Relatives | 890217 | Republic of Korea | 경기도 성남시 분당구 양현로 | - | Shareholder |
| 8 | 김우진 | Individual (Domestic) | Other | 690715 | Republic of Korea | 서울시 강남구 암구정로 | 제놀루션 임원 | Executives (unregistered) |
| 9 | 신희종 | Individual (Domestic) | Other | 830523 | Republic of Korea | 서울시 구로구 신도림로 | 제놀루션 임원 | Executives (unregistered) |
| 10 | 이순신 | Individual (Domestic) | Other | 610328 | Republic of Korea | 경기도 의왕시 새롬길21 | 제놀루션 임원 | Executives (unregistered) |
| 11 | 박정훈 | Individual (Domestic) | Other | 740706 | Republic of Korea | 경기도 화성시 동탄공원로 | 제놀루션 임원 | Executives (unregistered) |
| * Address to town/district level only |
(2) 특별관계자에 대한 구체적인 사항[진엑스]
| Legal form | Co., Ltd. |
| Total Assets (or Total Assets Under Management) | 40,322 | Total Liabilities | 19,976 |
| Total Equity | 20,346 | Paid-in Capital | 600 |
| Representative (representative or managing partner) | 김민호, 김기옥 |
| Decision-Making Body (Decision Maker) | Representative |
| Largest Shareholder (Largest Investor) | 김민호 | Largest Shareholder Ownership (%) (Largest Investor Contribution Ratio) | 29.2 |
[EK Health Services Inc, USD]
| Legal form | Co., Ltd. |
| Total Assets (or Total Assets Under Management) | UD$27,101,459 | Total Liabilities | US$1,614,461 |
| Total Equity | US$25,486,998 | Paid-in Capital | US$20,000 |
| Representative (representative or managing partner) | Eunhee Kim |
| Decision-Making Body (Decision Maker) | Representative |
| Largest Shareholder (Largest Investor) | Eunhee Kim | Largest Shareholder Ownership (%) (Largest Investor Contribution Ratio) | 100.0 |
c. Collective investment manager
(Only if the reporting person or specially related party is a "collective investment vehicle" under Regulation Art. 3-10(2))
(1) Collective investment manager overview
| No. | Name | Business Registration No., etc. | Target collective investment vehicle | Nationality | Address (Location) | Remarks |
| - | - | - | - | - | - | - |
| - | - | - | - | - | - | - |
(2) Collective investment manager details
| Legal form | - |
| Paid-in Capital | - | Total Assets Under Management | - |
| Representative | - |
| Decision-Making Body (Decision Maker) | - |
| Largest Shareholder (Corporate Representative) | - | Largest Shareholder Stake | - |
3. Shares, etc. held and holding ratio
| Report reference date | Reporting person | Shares, etc. | Share Certificates | Total Issued Voting Shares (shares) |
| Name of Holder | Number of Specially Related Persons | Number of Shares, etc. (shares) | Ratio (%) | Number of Shares (shares) | Ratio (%) |
| Previous Report | 2026.10.16 | 김기옥 | 11 | 5,497,927 | 28.65 | 5,497,927 | 28.65 | 19,190,021 |
| This Report | 2026.11.10 | 김기옥 | 11 | 5,527,927 | 28.81 | 5,527,927 | 28.81 | 19,190,021 |
| Change | 30,000 | 0.16 | 30,000 | 0.16 | 19,190,021 |
4. Purpose of holding
| Impact on management control |
| 보고자 본인은 자본시장법과 금융투자업에 관한 법률 시행령 제 154조 제1항 각 호와 같은 경영사항 모두에 대하여 영향력을 행사할 목적으로 주식을 보유하고 있으며, 향후 각각의 경영사항이 발생할 경우 주주 및 회사의 이익을 극대화하는 방향으로 관련 행위들을 결정할 것입니다.※ 자본시장과 금융투자업에 관한 법률 시행령 제 154조 제 1항 각 호1. 이사 및 감사의 선임. 해임 또는 직무의 정지2. 이사회 등 회사의 기관과 관련된 정관의 변경3. 회사의 자본금의 변경4. 회사의 배당금의 결정5. 회사의 합병, 분할 및 분할합병6. 주식의 포괄적 교환 및 이전7. 영업전부의 양수, 양도 또는 금융위원회가 정하여 고시하는 중요한 일부의 양수, 양도8. 자산의 전부의 처분 또는 금융위원회가 정하여 고시하는 중요한 일부의 처분9. 영업전부의 임대 또는 경영위임, 타인과 영업의 손익전부를 같이 하는 계약, 그 밖에 이에 준하는 계약의 체결, 변경 또는 해약10. 회사의 해산 등 |
5. Reason for change
| Method of change | On-market purchase |
| Reason for change | 단순 추가취득 |
| Reason for Change | - |
Part 2 Details of Large Holdings
1. Holdings by reporting person and specially related persons
A. Holdings by type of shares, etc.
| Relationship | Name | Date of Birth or Business Registration No., etc. | Details of Shares Held |
| Share certificates | Instruments representing preemptive rights | Convertible bonds | Bonds with warrants | Exchangeable bonds | Depositary receipts | Other | Total |
| Voting Shares | Shares Redeemable into Voting Shares | Shares Convertible into Voting Shares | Number of shares | Ratio (%) |
| Reporting person | 김기옥 | 551002 | 3,472,360 | - | - | - | - | - | - | - | - | 3,472,360 | 18.09 |
| Specially Related Party | 김민이 | 861116 | 728,721 | - | - | - | - | - | - | - | - | 728,721 | 3.80 |
| KimSangHoon | 600912 | 408,000 | - | - | - | - | - | - | - | - | 408,000 | 2.13 |
| 김민호 | 850701 | 679,038 | - | - | - | - | - | - | - | - | 679,038 | 3.54 |
| (주)호일바이오메드 | 209-81-13983 | 30,000 | - | - | - | - | - | - | - | - | 30,000 | 0.16 |
| EK Health Services Inc | 77-0497964 | 141,400 | - | - | - | - | - | - | - | - | 141,400 | 0.74 |
| 최영백 | 810521 | 13,368 | - | - | - | - | - | - | - | - | 13,368 | 0.07 |
| 김소현 | 890217 | 4,040 | - | - | - | - | - | - | - | - | 4,040 | 0.02 |
| 김우진 | 690715 | 29,500 | - | - | - | - | - | - | - | - | 29,500 | 0.15 |
| 신희종 | 830523 | 6,500 | - | - | - | - | - | - | - | - | 6,500 | 0.03 |
| 이순신 | 610328 | 5,000 | - | - | - | - | - | - | - | - | 5,000 | 0.03 |
| 박정훈 | 740706 | 10,000 | - | - | - | - | - | - | - | - | 10,000 | 0.05 |
| A | a1 | a2 | B | C | D | E | F | G | | |
| H |
| Total Issued Voting Shares (I) | Number of Potential Shares Held (a1+a2+B+C+D+E+F+G=H) | Holding Ratio (%) |
| Holding Ratio of Shares, etc. [A+H / I+H-(E+F+G)※] × 100 | Share Holding Ratio (A / I) × 100 |
| 19,190,021 | - | 28.81 | 28.81 |
※ Holding ratio calculated excluding from the denominator only exchangeable bonds exchangeable into shares, depositary receipts and derivative-linked securities with shares as underlying, and stock options settled in treasury shares
B. Holdings by form of holding
| Relationship | Name (Entity Name) | Date of Birth or Business Registration No., etc. | Type of holding equivalent to ownership (Article 142, Enforcement Decree of the Financial Investment Services and Capital Markets Act) | Total |
| No. 1 | No. 2 | No. 3 | No. 4 | No. 5 | No. 6 | No. 7 | Number of shares | Ratio |
| Reporting person | 김기옥 | 551002 | 3,472,360 | - | - | - | - | - | - | 3,472,360 | 18.09 |
| Specially Related Party | 김민이 | 861116 | 728,721 | - | - | - | - | - | - | 728,721 | 3.80 |
| KimSangHoon | 600912 | 408,000 | - | - | - | - | - | - | 408,000 | 2.13 |
| 김민호 | 850701 | 679,038 | - | - | - | - | - | - | 679,038 | 3.54 |
| (주)호일바이오메드 | 209-81-13983 | 30,000 | - | - | - | - | - | - | 30,000 | 0.16 |
| EK Health Services Inc | 77-0497964 | 141,400 | - | - | - | - | - | - | 141,400 | 0.74 |
| 최영백 | 810521 | 13,368 | - | - | - | - | - | - | 13,368 | 0.07 |
| 김소현 | 890217 | 4,040 | - | - | - | - | - | - | 4,040 | 0.02 |
| 김우진 | 690715 | 29,500 | - | - | - | - | - | - | 29,500 | 0.15 |
| 신희종 | 830523 | 6,500 | - | - | - | - | - | - | 6,500 | 0.03 |
| 이순신 | 610328 | 5,000 | - | - | - | - | - | - | 5,000 | 0.03 |
| 박정훈 | 740706 | 10,000 | - | - | - | - | - | - | 10,000 | 0.05 |
| ※ Holdings equivalent to ownership (Article 142, Enforcement Decree of the Financial Investment Services and Capital Markets Act) - Item 1: owning shares, etc. for one's own account, in whatever name - Item 2: holding a right to claim delivery of shares, etc. under law, a sale, or other contract - Item 3: holding voting rights (including the right to direct voting) over the shares, etc. under law, a money trust, security, or other contract - Item 4: holding the authority to acquire or dispose of the shares, etc. under law, a money trust, security, discretionary investment, or other contract - Item 5: acquiring, through a unilateral reservation for sale of shares, etc., the right to complete the sale, and holding buyer status by exercising that right - Item 6: holding contractual rights under Article 5(1)(2) of the Act with shares, etc. as underlying assets, and holding buyer status by exercising those rights - Item 7: being granted stock options and holding buyer status by exercising them |
2. Contracts on shares held
A. Contract status
| Execution or amendment of key agreements (trust, collateral, lending, discretionary, OTC trading, joint holding, etc.) |
| None |
*Voting rights on unreported holdings may be restricted if execution/amendment of material contracts is not reported
*2026-10-14 특수관계자간 장외매매계약을 체결하고 당일 거래가 완료되어 공시제출일 현재 계약은 종료되었습니다.
B. Contract details
| No. | Name (Entity Name) | Relationship to Reporter | Date of Birth or Business Registration No., etc. | Type of shares, etc. | Number of shares, etc. | Counterparty | Contract type | Contract date (amendment date) | Contract period | Ratio | Remarks |
| - | - | - | - | - | - | - | - | - | - | - | - |
| Total (number of shares, etc.) | 0 | Total (ratio) | - | - |
C. Additional details if the main contract is a security agreement
| No. | Number of shares, etc. | Loan amount | Debtor | Interest rate | Collateral maintenance ratio | Other |
| - | - | - | - | - | - | - |
| - | - | - | - | - | - | - |
3. Holdings by proprietary and customer account (financial institutions only)
| Name | Relationship to Reporter | By account | Total |
| Own Account (shares) | Ratio (%) | Customer account (shares) | Ratio (%) | Total (shares) | Ratio (%) |
| - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - |
| Total | - | - | - | - | - | - |
Part 3 Material Changes Since Last Report Date
1. Summary of changes
a. Changes in shares, etc.
| Relationship | Name | Date of Birth or Business Registration No., etc. | Details of Changes in Shares, etc. |
| Share certificates | Instruments representing preemptive rights | Convertible bonds | Bonds with warrants | Exchangeable bonds | Depositary receipts | Other | Total |
| Voting Shares | Shares Redeemable into Voting Shares | Shares Convertible into Voting Shares | Number of shares | Ratio (%) |
| Reporting person | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Specially Related Party | (주)호일바이오메드 | 209-81-13983 | 30,000 | - | - | - | - | - | - | - | - | 30,000 | 0.16 |
| - | - | - | - | - | - | - | - | - | - | - | - | - |
2. Change details
a. Detailed changes in shares, etc.
| Name (Entity Name) | Date of Birth or Business Registration No., etc. | Change Date* | Acquisition/disposal method | Type of shares, etc. | Change details | Acquisition/disposal unit price** | Remarks |
| Before Change | Change | After Change |
| (주)호일바이오메드 | 209-81-13983 | 2026.11.03 | On-Market Purchase (+) | Voting Shares | 0 | 27 | 27 | 1,710 | - | - |
| (주)호일바이오메드 | 209-81-13983 | 2026.11.04 | On-Market Purchase (+) | Voting Shares | 27 | 8,973 | 9,000 | 1,749 | - | - |
| (주)호일바이오메드 | 209-81-13983 | 2026.11.05 | On-Market Purchase (+) | Voting Shares | 9,000 | 3,000 | 12,000 | 1,723 | - | - |
| (주)호일바이오메드 | 209-81-13983 | 2026.11.06 | On-Market Purchase (+) | Voting Shares | 12,000 | 2,000 | 14,000 | 1,709 | - | - |
| (주)호일바이오메드 | 209-81-13983 | 2026.11.09 | On-Market Purchase (+) | Voting Shares | 14,000 | 6,000 | 20,000 | 1,719 | - | - |
| (주)호일바이오메드 | 209-81-13983 | 2026.11.10 | On-Market Purchase (+) | Voting Shares | 20,000 | 10,000 | 30,000 | 1,731 | - | - |
* For trades on the securities market, the contract date
** For securities other than shares, the exercise (conversion/exchange) price of the securities or the unit price of shares acquired/disposed of through exercise of rights; amounts in ( ) are the unit price of the securities
3. Source of acquisition funds
(1) Overview of acquisition funds
| Name | Date of birth or business registration no., etc. | Own funds (H) | Borrowings (I) | Other (J) | Total (H+I+J) |
| (주)호일바이오메드 | 209-81-13983 | 51,959,398 | - | - | 51,959,398 |
(2) Origin and source of acquisition funds
ㅇ If own funds
| Name | Date of birth or business registration no., etc. | Source and Formation of Acquisition Funds |
| (주)호일바이오메드 | 209-81-13983 | 사업 소득 |